Global Oncology Market Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors, Forecasted CAGR Growth at 10.66% by 2023
According to a precise analysis, there are 32.6 million people living with any type of cancer within the five years of diagnosis. The cancer type is generally incurable once they progress to the stage where they are unresectable, making Oncology an important part of medical science. To discuss the robust growth of the oncology market, Market Research Hub (MRH) has recently added a detailed study titled as "Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and...
View full press release